Literature DB >> 6270447

Responsiveness of plasma renin and aldosterone in diabetes mellitus.

C Beretta-Piccoli, P Weidmann, G Keusch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270447     DOI: 10.1038/ki.1981.129

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  7 in total

1.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

2.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

3.  Plasma renin activity and urinary kallikrein excretion in response to intravenous furosemide in diabetic patients.

Authors:  S B Lall; S Kunchaparty; H H Siddiqui; J S Bajaj
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

Review 4.  [The renin-angiotensin system in diabetic patients].

Authors:  J Mann; E Ritz
Journal:  Klin Wochenschr       Date:  1988-09-15

5.  Knockout of Macula Densa Neuronal Nitric Oxide Synthase Increases Blood Pressure in db/db Mice.

Authors:  Jie Zhang; Ximing Wang; Yu Cui; Shan Jiang; Jin Wei; Jenna Chan; Anish Thalakola; Thanh Le; Lan Xu; Liang Zhao; Lei Wang; Kun Jiang; Feng Cheng; Trushar Patel; Jacentha Buggs; Volker Vallon; Ruisheng Liu
Journal:  Hypertension       Date:  2021-10-18       Impact factor: 10.190

Review 6.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04

7.  Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.

Authors:  C Ferrier; P Ferrari; P Weidmann; U Keller; C Beretta-Piccoli; W F Riesen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.